Salix Pharmaceuticals
400 Somerset Corporate Blvd.,
Bridgewater, 08807, NJ,
United States
Bridgewater, 08807, NJ,
United States
1 800-321-4576
Life Sciences
Salix Pharmaceuticals Technographics
Salix Pharmaceuticals Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Salix Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 7100 Salix Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Salix Pharmaceuticals has purchased the following applications: SAP Concur Expense for Expense Management in 2013, Aptean Ross ERP for Manufacturing ERP in 2008, Microsoft 365 for Collaboration in 2020 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Salix Pharmaceuticals is running and its propensity to invest more and deepen its relationship with SAP , Aptean , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Salix Pharmaceuticals revenues, which have grown to $1.90 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Salix Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Salix Pharmaceuticals Tech Stack and Enterprise Applications
Salix Pharmaceuticals ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| SAP | Legacy | SAP Concur Expense | Expense Management | ERP | n/a | 2013 | 2013 |
In 2013, Salix Pharmaceuticals implemented SAP Concur Expense to establish a centralized Expense Management capability for corporate finance and company-wide expense reporting. Salix Pharmaceuticals deployed SAP Concur Expense to manage expense reporting, approvals, and policy enforcement across employees and manager approvers.
The implementation configured SAP Concur Expense to audit and approve company expense reports for payment, using structured approval workflows and the application’s policy enforcement controls to flag exceptions. The program provided training and support to all employees on the expense reporting system, and operational processes were established to monitor employee compliance with the T&E Policy. Salix tracked policy infractions within SAP Concur Expense for inter-department review and compliance oversight.
Operational coverage extended across finance, manager approvers, and departmental reviewers, with processes to monitor expense report queue activity and to work with managers to balance workloads during peak volume times and monthly deadlines. The deployment emphasized centralized queue management and routed approvals to ensure timely processing and payment authorization. Functional terminology used in the implementation includes expense reporting, approval routing, queue monitoring, exception handling, and policy violation tracking within the Expense Management environment.
Governance incorporated ongoing training programs, defined escalation paths for policy infractions, and routine monitoring of queue activity to support monthly close cycles. The implementation positioned SAP Concur Expense as Salix Pharmaceuticals core Expense Management system for expense auditing, approval, and compliance tracking.
|
Salix Pharmaceuticals ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Aptean | Legacy | Aptean Ross ERP | Manufacturing ERP | ERP Services and Operations | n/a | 2008 | 2008 |
In 2008 Salix Pharmaceuticals implemented Aptean Ross ERP, deploying the Aptean Ross ERP solution classified as Manufacturing ERP. The implementation is described in operational terms rather than project replacement language, with ongoing technical stewardship focused on system availability and data integrity.
Aptean Ross ERP at Salix is managed as an enterprise application with technical responsibilities that include backup and recovery, data management, change management, and process documentation. The technical manager is the primary custodian for ERP data lifecycle activities, ensuring database backups, recovery procedures, and controlled configuration changes are maintained as part of ERP operations.
The broader application landscape supporting revenue and commercial processes includes a multi environment, multi tiered technology stack associated with the Revenue Management Model N application, explicitly using Oracle databases, Enterprise Manager, WebLogic, GoldenGate, Data Guard, Informatica, QlikView, and Cognos alongside server management. Salix’s operational scope includes full Oracle database administration, backup and recovery process ownership, data replication management, and security administration across these environments.
Governance and operational controls are centralized under IT management responsibilities that include oversight of an Oracle Managed Services team, IT business relationship management, and ticket management workflows. Process documentation and change management practices for Aptean Ross ERP are enforced through these governance channels, aligning ERP technical operations with enterprise IT support and service processes.
|
Salix Pharmaceuticals Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2020 | 2020 |
In 2020, Salix Pharmaceuticals implemented Microsoft 365 for Collaboration. Publicly observable site assets indicate Microsoft 365 is in use on their website, confirming adoption of Microsoft 365 as the organization’s collaboration platform.
The Microsoft 365 deployment centers on core Collaboration workloads, covering email and calendar, real-time meetings and chat, cloud file storage, and document co-authoring. Typical components in scope include Exchange Online, Microsoft Teams, SharePoint Online, and OneDrive for Business, which together provide integrated messaging, synchronous collaboration, and content services.
Architecturally the implementation aligns with a cloud-first Microsoft 365 tenant model managed through centralized administration, enabling role-based administration and policy enforcement at the tenant level. Operational coverage emphasizes corporate collaboration workflows and content lifecycle governance rather than specific clinical or ERP systems, none of which are specified in the source.
Governance and operational controls associated with this Collaboration deployment follow Microsoft 365 patterns, including identity and access controls via Azure Active Directory, centralized retention and sharing policies, and tenant-level compliance settings. The record therefore establishes Salix Pharmaceuticals Microsoft 365 Collaboration as the primary platform for enterprise communication and content management.
|
|
|
|
|
Event Management | Collaboration |
|
2019 | 2019 |
|
Salix Pharmaceuticals Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Digital Signing | Content Management |
|
2021 | 2021 |
|
|
|
|
|
Web Content Management | Content Management |
|
2015 | 2015 |
|
Salix Pharmaceuticals CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
CRM | CRM |
|
2015 | 2015 |
|
|
|
|
|
Marketing Automation | CRM |
|
2014 | 2014 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
Salix Pharmaceuticals TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2007 | 2014 |
|
Salix Pharmaceuticals PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Apps Development | PaaS |
|
2022 | 2022 |
|
Salix Pharmaceuticals IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2014 | 2014 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2018 | 2018 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
Salix Pharmaceuticals CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2013 | 2013 |
|
|
|
|
|
Web Application Firewalls (WAF) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Salix Pharmaceuticals
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
Associate Director, Clinical Operations | Director | Operations | |
|
|
|
Accounts Payable Clerk | Manager | Finance | |
|
|
|
Sr Manager IT, Corporate Applications | Manager | IT | |
|
|
|
CEO | CXO | Finance | |
|
|
|
On-Site Travel Consultant | Manager | Finance | |
|
|
|
Hospital Key Account Manager | Manager | Finance | |
|
|
|
Regional Account Manager | Manager | Finance | |
|
Apps Being Evaluated by Salix Pharmaceuticals Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Salix Pharmaceuticals IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Salix Pharmaceuticals digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Salix Pharmaceuticals Technographics
Salix Pharmaceuticals is a Life Sciences organization based in United States,
with around 7100 employees and annual revenues of $1.90 billion.
Salix Pharmaceuticals operates a diverse technology stack with applications such as
SAP Concur Expense, Aptean Ross ERP and Microsoft 365,
covering areas like Expense Management, Manufacturing ERP and Collaboration.
Salix Pharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as SAP, Aptean and Microsoft.
Salix Pharmaceuticals recently adopted applications including
Bubble Platform in 2022, DocuSign eSignature in 2021 and Salesforce Sales Cloud in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Salix Pharmaceuticals’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Salix Pharmaceuticals’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Salix Pharmaceuticals technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.